Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$16.95 - $27.04 $160,855 - $256,609
9,490 Added 12.39%
86,070 $2.33 Million
Q1 2024

May 07, 2024

BUY
$11.38 - $19.03 $82,914 - $138,652
7,286 Added 10.51%
76,580 $1.4 Million
Q4 2023

Feb 06, 2024

SELL
$6.29 - $15.72 $141,336 - $353,228
-22,470 Reduced 24.49%
69,294 $850,000
Q3 2023

Nov 02, 2023

BUY
$14.99 - $32.65 $118,301 - $257,673
7,892 Added 9.41%
91,764 $1.38 Million
Q2 2023

Aug 09, 2023

BUY
$29.76 - $46.14 $330,008 - $511,646
11,089 Added 15.24%
83,872 $2.73 Million
Q1 2023

May 11, 2023

SELL
$38.09 - $57.79 $8,075 - $12,251
-212 Reduced 0.29%
72,783 $2.85 Million
Q4 2022

Feb 13, 2023

BUY
$40.54 - $56.2 $672,923 - $932,863
16,599 Added 29.43%
72,995 $3.86 Million
Q4 2022

Feb 13, 2023

SELL
$40.54 - $56.2 $741,192 - $1.03 Million
-18,283 Reduced 24.48%
56,396 $2.98 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $106,872 - $142,188
2,890 Added 4.03%
74,679 $3.36 Million
Q2 2022

Aug 05, 2022

BUY
$28.03 - $45.8 $331,987 - $542,455
11,844 Added 19.76%
71,789 $2.61 Million
Q1 2022

May 09, 2022

BUY
$29.24 - $44.06 $85,322 - $128,567
2,918 Added 5.12%
59,945 $2.48 Million
Q4 2021

Feb 07, 2022

SELL
$39.32 - $61.61 $102,192 - $160,124
-2,599 Reduced 4.36%
57,027 $2.43 Million
Q3 2021

Oct 28, 2021

BUY
$44.0 - $65.8 $112,420 - $168,119
2,555 Added 4.48%
59,626 $3.28 Million
Q2 2021

Aug 13, 2021

BUY
$44.66 - $63.06 $870,155 - $1.23 Million
19,484 Added 51.84%
57,071 $2.73 Million
Q1 2021

May 06, 2021

BUY
$46.31 - $62.7 $206,125 - $279,077
4,451 Added 13.43%
37,587 $1.9 Million
Q4 2020

Feb 12, 2021

BUY
$55.51 - $69.94 $219,097 - $276,053
3,947 Added 13.52%
33,136 $2.09 Million
Q3 2020

Nov 06, 2020

BUY
$42.19 - $69.61 $297,861 - $491,446
7,060 Added 31.9%
29,189 $1.96 Million
Q2 2020

Jul 29, 2020

BUY
$27.55 - $43.28 $609,653 - $957,743
22,129 New
22,129 $926,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.